DE60127379D1 - Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung - Google Patents

Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung

Info

Publication number
DE60127379D1
DE60127379D1 DE60127379T DE60127379T DE60127379D1 DE 60127379 D1 DE60127379 D1 DE 60127379D1 DE 60127379 T DE60127379 T DE 60127379T DE 60127379 T DE60127379 T DE 60127379T DE 60127379 D1 DE60127379 D1 DE 60127379D1
Authority
DE
Germany
Prior art keywords
linezolid
taste
masked
fast
disintegrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60127379T
Other languages
English (en)
Inventor
Phillip J Percel
Gopi M Venkatesh
Krishna S Vishnupad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adare Pharmaceuticals Inc
Original Assignee
Eurand America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand America Inc filed Critical Eurand America Inc
Application granted granted Critical
Publication of DE60127379D1 publication Critical patent/DE60127379D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
DE60127379T 2000-01-20 2001-01-16 Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung Expired - Lifetime DE60127379D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17723300P 2000-01-20 2000-01-20
US09/506,051 US6451345B1 (en) 2000-01-20 2000-02-17 Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
PCT/US2001/001414 WO2001052848A2 (en) 2000-01-20 2001-01-16 Functional coating of linezolid microcapsules for oral administration

Publications (1)

Publication Number Publication Date
DE60127379D1 true DE60127379D1 (de) 2007-05-03

Family

ID=26873062

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60127379T Expired - Lifetime DE60127379D1 (de) 2000-01-20 2001-01-16 Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung

Country Status (6)

Country Link
US (1) US6451345B1 (de)
EP (1) EP1248616B1 (de)
AT (1) ATE357231T1 (de)
AU (1) AU2001227915A1 (de)
DE (1) DE60127379D1 (de)
WO (1) WO2001052848A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin
US7488496B2 (en) 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
AU2002368090A1 (en) * 2002-07-17 2004-02-09 Eurand Pharmaceuticals Ltd Process for the preparation of pharmaceutical microcapsules with enhanced tastemasking and high dissolution rate
CA2492874C (en) * 2002-07-19 2011-09-20 Aventis Pharma S.A. Taste masked oral composition of telithromycin
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
US20040208936A1 (en) * 2002-07-22 2004-10-21 Roland Chorin Novel compositions
US6875784B2 (en) * 2002-10-09 2005-04-05 Pharmacia & Upjohn Company Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20040265372A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
US8168228B2 (en) * 2003-10-17 2012-05-01 Sandoz Ag Antibiotic clarithromycin micropellet compositions
US7387793B2 (en) 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
US8545881B2 (en) 2004-04-19 2013-10-01 Eurand Pharmaceuticals, Ltd. Orally disintegrating tablets and methods of manufacture
IS7724A (is) * 2005-03-02 2006-09-03 Actavis Group Samsetning á töflum með hraða sundrun sem innihalda þungt magnesíum karbónat
US20070098746A1 (en) * 2005-11-02 2007-05-03 Nichols William M Multi-layered coating technology for taste masking
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
JP5228359B2 (ja) * 2007-04-12 2013-07-03 ニプロ株式会社 主薬粒子及びその製造方法ならびに口腔内崩壊錠
FR2918296B1 (fr) 2007-07-05 2009-09-18 Oreal Capsules de type noyau/ecorce et procede de preparation
TW200938186A (en) * 2008-02-13 2009-09-16 Eurand Inc Orally disintegrating tablet compositions of ranitidine and methods of manufacture
WO2010046933A2 (en) 2008-10-22 2010-04-29 Rubicon Research Private Limited Pharmaceutical compositions of taste-masked linezolid
CA2750059C (en) 2009-01-30 2014-11-18 Sunovion Pharmaceuticals Inc. Coated tablets of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine and methods for measuring effectiveness of coating
WO2011080570A2 (en) 2009-12-29 2011-07-07 Micro Labs Limited Extended release pharmaceutical composition comprising linezolid and process for preparing the same
CA2802994A1 (en) 2010-06-17 2011-12-22 The United States Of America As Represented By The Secretary, National I Nstitutes Of Health Compositions and methods for treating inflammatory conditions
KR101944124B1 (ko) * 2010-11-24 2019-01-30 멜린타 서브시디어리 코프. 약학 조성물
CA2778748A1 (en) * 2011-06-01 2012-12-01 Nitto Denko Corporation Particulate preparation and method for producing the same
EP2719377B1 (de) * 2011-06-10 2018-04-18 Nipro Corporation Verfahren zur herstellung von im mund zersetzbaren tabletten
WO2013088389A1 (en) * 2011-12-14 2013-06-20 Alembic Pharmaceuticals Limited Linezolid premix
GR1008143B (el) 2013-03-11 2014-03-14 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα περιεχον ενα οξαζολιδινονικο αντιβακτηριακο παραγοντα και μεθοδος για την παρασκευη αυτου
CN104739788B (zh) * 2013-12-27 2018-02-16 桂林南药股份有限公司 一种小儿利奈唑胺组合物冻干口腔崩解片及其制备方法
EP3110403B1 (de) * 2014-02-25 2019-11-06 Orbis Biosciences, Inc. Geschmacksmaskierende arzneimittelformulierungen
CN105055354B (zh) * 2015-09-08 2017-11-21 深圳万乐药业有限公司 一种利奈唑胺片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800087A (en) 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4948801A (en) 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
US5082669A (en) 1989-07-20 1992-01-21 Dainippon Pharmaceutical Co., Ltd. Rapid-releasing oral particle pharmaceutical preparation with unpleasant taste masked
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5075114A (en) 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2122286A1 (en) * 1993-04-28 1994-10-29 Hiroshi Matoba Solid preparation and its production
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
ES2193592T3 (es) 1997-11-18 2003-11-01 Upjohn Co Uso de derivados de la oxazolidinona para el tratamiento de la artritis.
CA2318969A1 (en) 1998-01-23 1999-07-29 Mikhail F. Gordeev Oxazolidinone combinatorial libraries, compositions and methods of preparation

Also Published As

Publication number Publication date
WO2001052848A3 (en) 2001-12-13
EP1248616B1 (de) 2007-03-21
US6451345B1 (en) 2002-09-17
EP1248616A2 (de) 2002-10-16
ATE357231T1 (de) 2007-04-15
AU2001227915A1 (en) 2001-07-31
WO2001052848A2 (en) 2001-07-26

Similar Documents

Publication Publication Date Title
DE60127379D1 (de) Funktionelle beschichtung von linezolidmikrokapseln zur geschmacksmaskierung und damit verbundene oral anzuwendende arzneizubereitung
Nagar et al. Orally disintegrating tablets: formulation, preparation techniques and evaluation
EP1248594B1 (de) Formulierung mit mehrfach gepulster wirkstofffreisetzung
HUP0201877A2 (hu) Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák
ES2201465T3 (es) Formulado de comprimidos de monohidrato de cefadroxil.
IL163653A (en) Wafer-shaped pharmaceutical preparation for administering active substances having an unpleasant or bitter taste via the oral mucosa and use of at least one carbon dioxide-forming substance for masking the unpleasant taste of said preparation
DE69527842D1 (de) Oral anzuwendendes flüssiges arzneimittel enthaltend alendronat
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
CA2307018A1 (en) Osmotic medicament releasing system
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
WO2002067903A3 (en) Compositions and methods of manufacture for oral dissolvable dosage forms
AU2002216701A1 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1161956A4 (de) Medikamentenzusammensetzung
HUP0000943A2 (hu) Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban
DE69519685D1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
US5702723A (en) Multi-stage delivery system for ingestible medications or nutrients
CA2653030A1 (en) Ache-nmda combination wafer
HUP0105481A2 (hu) Klaritromicint vagy származékait tartalmazó gyógyászati készítmények és eljárás előállításukra, valamint alkalmazásuk
CA2652476A1 (en) Combination antidepressants wafer
EA012324B1 (ru) Быстрораспадающаяся таблетка
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
EP0271151A3 (de) Azumolen-Dosisformen
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
US9339475B2 (en) Spatial arrangement of particles in a drinking device for oral delivery of pharmaceuticals
US20180318228A1 (en) Method for a slow release of drugs from orally dissolving capsules

Legal Events

Date Code Title Description
8332 No legal effect for de